SEC Form 4 · accession 0001209191-18-025382
ANAPTYSBIO, INC · ANAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Lydon
Director
Period of report
Apr 16, 2018
Accepted (ET)
Apr 18, 2018 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001370053
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Apr 16, 2018 | S | 2,600 | $84.1846 | D | 301,506 | D | |
| Common StockF2,F4 | Apr 16, 2018 | S | 10,310 | $85.1107 | D | 291,196 | D | |
| Common StockF2,F5 | Apr 16, 2018 | S | 1,390 | $86.1532 | D | 289,806 | D | |
| Common StockF2,F6 | Apr 16, 2018 | S | 9,425 | $87.4632 | D | 280,381 | D | |
| Common StockF2,F7 | Apr 16, 2018 | S | 4,250 | $88.2982 | D | 276,131 | D | |
| Common StockF2,F8 | Apr 16, 2018 | S | 2,803 | $89.4154 | D | 273,328 | D | |
| Common StockF2,F9 | Apr 16, 2018 | S | 2,222 | $90.2561 | D | 271,106 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- F2Represents the aggregate of sales effected on the same day at different prices.
- F3Represents the weighted average sales price per share. The shares sold at prices ranging from $83.69 to $84.64 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- F4Represents the weighted average sales price per share. The shares sold at prices ranging from $84.75 to $85.74 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- F5Represents the weighted average sales price per share. The shares sold at prices ranging from $85.75 to $86.73 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- F6Represents the weighted average sales price per share. The shares sold at prices ranging from $86.91 to $87.895 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- F7Represents the weighted average sales price per share. The shares sold at prices ranging from $87.91 to $88.90 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- F8Represents the weighted average sales price per share. The shares sold at prices ranging from $88.91 to $89.87 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- F9Represents the weighted average sales price per share. The shares sold at prices ranging from $89.93 to $90.69 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.